Employment type: full time REQUEST FOR PROPOSALS My Cancer, My Choice - Phase 2 National Expansion Government Relations, Healthcare Stakeholder Engagement, Communications & Campaign Amplification Issued by: Save Your Skin Foundation RFP Issue Date: September 14, 2026 Proposal Deadline: October 5, 2026 Anticipated Campaign Period: November 2026 - February 2027 About Save Your Skin Foundation Save Your Skin Foundation (SYSF) is a Canadian patient-led organization dedicated to supporting people affected by cancer through education, advocacy, awareness and patient support. In 2026, SYSF and participating patient organizations launched My Cancer, My Choice, a patient community-led education and awareness campaign focused on helping Canadians understand that, in some cases, choices may exist in how cancer treatment is delivered, and that treatment delivery can affect time, comfort, day-to-day routines and the overall treatment experience. Phase 1 established a bilingual campaign platform and launched with a strong focus in Quebec, supported by patient and healthcare professional voices, earned and paid media, digital and social amplification, a public service announcement (PSA), and radio outreach. SYSF is now preparing for Phase 2: national expansion and provincial activation. Purpose of the RFP SYSF is seeking an experienced national agency or integrated agency team with demonstrated expertise in: Government relations and health policy; Provincial healthcare systems and reimbursement environments; Healthcare professional and institutional stakeholder engagement; Public relations and earned media; Paid and digital media strategy and execution; Patient and public advocacy campaigns; and Bilingual English/French communications. The selected agency will work with SYSF to develop and execute a coordinated national strategy that is provincially tailored rather than uniformly deployed across Canada. The agency must demonstrate meaningful national reach and, critically, strong provincial expertise, relationships and on-the-ground capabilities across key Canadian provinces. Phase 2 Strategic Objective Phase 2 will build upon the awareness, education, partnerships, creative platform and campaign infrastructure developed during Phase 1. The objective is to advance appropriate access to and adoption of subcutaneous (SubQ) oncology treatment delivery across Canada while continuing to centre the patient experience, informed treatment conversations and healthcare system sustainability. Phase 2 will operate through a two-pillared strategic framework: “The Implementers” and “The Changers.” This reflects the significant differences in formulary status, healthcare delivery and institutional adoption between provinces. Pillar 1: The Implementers: Ground-Level Adoption In provinces where relevant SubQ treatment options are already publicly listed, the focus will shift from access advocacy toward implementation and uptake within the healthcare system. Priority audiences may include: Oncologists | Oncology Nurses | Hospital Administrators | Pharmacy Directors | Cancer Centre Leadership | Health Authorities The strategy should help address barriers to adoption and demonstrate the potential value of SubQ delivery in areas such as: Healthcare system capacity; Infusion chair utilization; Clinical workflow; Nursing and staffing pressures; Patient intake and institutional processes Patient treatment experience. The Phase 2 framework currently identifies British Columbia, Quebec and the Atlantic provinces within the Implementers pillar. Quebec represents a particular opportunity, as listing occurred relatively early but uptake and patient intake remain slower. Pillar 2: The Changers: Policy & Listing Adoption In provinces where SubQ listing remains pending, delayed or stalled, the campaign will focus on creating an environment that supports policy action and formulary access. Priority audiences may include: Provincial Decision-Makers | Health Authorities | Patient Advocates | Healthcare Professionals | Media | General Public Potential tactics may include: Government relations and policy engagement; Grassroots advocacy; Patient mobilization; Letter-writing or other public-action campaigns; Earned media; Targeted public awareness; Stakeholder coalition building; and Strategic paid media directed toward priority audiences. Ontario and Alberta are currently expected to fall within the Changers pillar. These efforts are intended to complement, rather than replace or duplicate, formal pharmaceutical pricing and listing negotiations. Provincial Approach Phase 2 must remain flexible as provincial listing environments evolve. The current working framework is: Province/Region Current Direction Primary Focus British Columbia Implementers Clinical/institutional adoption and system capacity Atlantic Canada Implementers Clinical/institutional adoption and system capacity Quebec Implementers Accelerating uptake and addressing institutional barriers Ontario Changers Formulary access, advocacy and policy engagement Alberta Changers Formulary access, advocacy and policy engagement Manitoba Dynamic Monitor listing; Changers if delayed → Implementers once listed Saskatchewan Dynamic Monitor listing; Changers if delayed → Implementers once listed The selected agency will be expected to monitor the provincial environment and recommend adjustments as circumstances change. The Phase 2 framework specifically anticipates Manitoba and Saskatchewan potentially moving from Changers-oriented activity to Implementers activity following listing. Existing Campaign Foundation SYSF is not seeking to rebuild the campaign from the ground up. A significant creative and communications foundation has already been developed through Phase 1 and should be leveraged wherever appropriate. Existing resources include: Established My Cancer, My Choice / Mon cancer, mon choix campaign branding; Bilingual campaign microsite; English and French video PSA; Radio PSA; Existing social media graphics